Phase 3Not yet recruitingINTERVENTIONAL
A Clinical Study to Evaluate the Effects of Enicepatide Versus Tirzepatide in Participants With Type 2 Diabetes and Inadequate Blood Sugar Control on Oral Glucose-Lowering Medications
ClinicalTrials.gov · NCT07889648 · Registry updated: 2026-10-22
- Condition / research focus
- Type 2 Diabetes Mellitus
- Sponsor
- Hoffmann-La Roche
- Countries with listed sites
- No country reported
- Registry dates and results
- Start: 2026-12-01. Completion: 2029-04-23 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Enicepatide (combination_product) — also listed as: RO7795068, RG6640, CT-388
- Tirzepatide (combination_product)
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.